Gastrointestinal and Other Cancers Clinical Trials
| Title | Intervention |
NCT ID |
Sponsor | Status |
|---|---|---|---|---|
| Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps | Laboratory Biomarker Analysis, MUC1 Peptide-Poly-ICLC Vaccine, Quality-of-Life Assessment, Saline | NCT02134925 | National Cancer Institute (NCI) | Active, not recruiting |
| Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver | Erlotinib, Erlotinib Hydrochloride, Laboratory Biomarker Analysis, Quality-of-Life Assessment | NCT02273362 | National Cancer Institute (NCI) | Active, not recruiting |
| ASPirin Intervention for the REDuction of Colorectal Cancer Risk | Aspirin, Placebo for Aspirin | NCT02394769 | Massachusetts General Hospital | Active, not recruiting |
| Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful... | Aspirin, Laboratory Biomarker Analysis, Placebo Administration, Questionnaire Administration | NCT02521285 | National Cancer Institute (NCI) | Active, not recruiting |
| DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection | Electroporation-Mediated Plasmid DNA Vaccine Therapy, HCV DNA Vaccine INO-8000, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Rocakinogene Sifuplasmid | NCT02772003 | National Cancer Institute (NCI) | Active, not recruiting |
| Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric... | Curcumin, Laboratory Biomarker Analysis, Placebo Administration, Quality-of-Life Assessment | NCT02782949 | National Cancer Institute (NCI) | Active, not recruiting |
| Chemoprevention of Gastric Carcinogenesis | Eflornithine, Eflornithine placebo | NCT02794428 | Vanderbilt-Ingram Cancer Center | Active, not recruiting |
| Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma | Aspirin, Biospecimen Collection, Placebo Administration, Questionnaire Administration, Rectal Biopsy | NCT02965703 | National Cancer Institute (NCI) | Active, not recruiting |
| Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis | Placebo Administration, Questionnaire Administration, Simvastatin | NCT02968810 | National Cancer Institute (NCI) | Active, not recruiting |
| CHARM II: Chemotherapy for Ablation and Resolution of Mucinous Pancreatic Cysts | Ethanol, Normal saline, Paclitaxel + Gemcitabine admixture | NCT03085004 | Milton S. Hershey Medical Center | Recruiting |